Artwork

Content provided by Advisory Board. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Advisory Board or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

175: We need to talk about maternal health in America [Bonus content]

41:14
 
Share
 

Manage episode 374282221 series 2762568
Content provided by Advisory Board. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Advisory Board or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

(New/bonus content starts at 24:11. First part of episode originally aired October 5, 2021.)

This week, Radio Advisory is bringing you an encore of Ep. 91: We need to talk about maternal health in America, where host Rachel (Rae) Woods invites Advisory Board Expert Darby Sullivan and Optum Director of social responsibility Callie Chamberlain to discuss the dire state of maternal health in America.

Following the original episode, in a special bonus segment, host Rae Woods brings back Advisory Board health equity expert Darby Sullivan and invites women’s health expert Gaby Marmolejos to discuss why maternal health, and women’s health more broadly, are only getting worse. In the conversation, they discuss what is driving poor maternal outcomes and why there needs to be a massive shift in how the industry thinks about maternal health moving forward.

This episode was recorded before the FDA approved Zurzuvae (zuranolone), the first ever pill to treat post-partum depression. Postpartum depression is a condition that affects one in eight new mothers. Previously, the only treatment available was an IV infusion approved by the FDA, which required patients to be in the hospital for 2.5 days. The move underscores the industries' need to focus on behavioral health in the postpartum period and on women’s health more broadly.

Links:


Learn more about Advisory Board On-Demand Courses


Visit advisory.com/workforce to get research and insights that will help you understand the current challenges providers are facing and learn how technology – including platforms you may already have – can address healthcare's biggest staffing and care delivery challenges.


Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

  continue reading

230 episodes

Artwork
iconShare
 
Manage episode 374282221 series 2762568
Content provided by Advisory Board. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Advisory Board or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

(New/bonus content starts at 24:11. First part of episode originally aired October 5, 2021.)

This week, Radio Advisory is bringing you an encore of Ep. 91: We need to talk about maternal health in America, where host Rachel (Rae) Woods invites Advisory Board Expert Darby Sullivan and Optum Director of social responsibility Callie Chamberlain to discuss the dire state of maternal health in America.

Following the original episode, in a special bonus segment, host Rae Woods brings back Advisory Board health equity expert Darby Sullivan and invites women’s health expert Gaby Marmolejos to discuss why maternal health, and women’s health more broadly, are only getting worse. In the conversation, they discuss what is driving poor maternal outcomes and why there needs to be a massive shift in how the industry thinks about maternal health moving forward.

This episode was recorded before the FDA approved Zurzuvae (zuranolone), the first ever pill to treat post-partum depression. Postpartum depression is a condition that affects one in eight new mothers. Previously, the only treatment available was an IV infusion approved by the FDA, which required patients to be in the hospital for 2.5 days. The move underscores the industries' need to focus on behavioral health in the postpartum period and on women’s health more broadly.

Links:


Learn more about Advisory Board On-Demand Courses


Visit advisory.com/workforce to get research and insights that will help you understand the current challenges providers are facing and learn how technology – including platforms you may already have – can address healthcare's biggest staffing and care delivery challenges.


Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

  continue reading

230 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide